Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best PT-141 Dosage for Libido Enhancement: Protocol Comparison

0.5–0.75mg 60–120 min 4–8 hours 8–12% Individuals with high melanocortin receptor sensitivity; first-time users establishing baseline tolerance 1.0mg 45–90 min 6–12 hours 18–22% Standard starting dose for titration; suitable for users seeking moderate effect w

This comparison does not assign a generated winner or score.

  • 0.5–0.75mg
  • 60–120 min
  • 4–8 hours
  • 8–12%
  • Individuals with high melanocortin receptor sensitivity; first-time users establishing baseline tolerance
  • 1.0mg
  • 45–90 min
  • 6–12 hours
  • 18–22%
  • Standard starting dose for titration; suitable for users seeking moderate effect with minimized side effects
  • 1.75mg (FDA standard)
  • 30–90 min
  • 6–24 hours
  • 35–40%
  • Clinically validated dose for hypoactive sexual desire disorder; maximum efficacy for most users
  • 2.0–2.5mg
  • 30–60 min
  • 8–24 hours
  • 50–65%
  • Reserved for non-responders at 1.75mg under medical supervision; marginal efficacy gain with steep side effect trade-off
More references

Related material

Comparison

Nasal Spray vs Injection

PT-141 nasal spray is available from compounding pharmacies but was rejected by the FDA for good reason. Diamond et al. (2004, PMID: 14963471) studied intranasal bremelanotide and…

View details →